Cargando…

Abl Tyrosine Kinase Regulates Hepatitis C Virus Entry

Abl is a central regulator of multiple cellular processes controlling actin dynamics, proliferation, and differentiation. Here, we showed that knockdown of Abl impaired hepatitis C virus (HCV) propagation. Treatment of Abl tyrosine kinase-specific inhibitor, imatinib and dasatinib, also significantl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Min, Saehong, Lim, Yun-Sook, Shin, Dongjo, Park, Chorong, Park, Jae-Bong, Kim, Seungtaek, Windisch, Marc P., Hwang, Soon B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474468/ https://www.ncbi.nlm.nih.gov/pubmed/28674529 http://dx.doi.org/10.3389/fmicb.2017.01129

Ejemplares similares

Ankyrin Repeat Domain 1 is Up-regulated During Hepatitis C Virus Infection and Regulates Hepatitis C Virus Entry
por: Than, Thoa T., et al.
Publicado: (2016)

BCR-ABL tyrosine kinase inhibitor (TKI)-induced nephropathy: An under-recognized phenomenon
por: Stanchina, Michele, et al.
Publicado: (2020)

5-Oxo-1-[(2,3,6,7-tetramethoxy-9-phenanthrenyl)methyl]-L-proline Inhibits Hepatitis C Virus Entry
por: Nguyen, Lap P., et al.
Publicado: (2019)

Constitutive Activity in an Ancestral Form of Abl Tyrosine Kinase
por: Aleem, Saadat U., et al.
Publicado: (2015)

Bcr-Abl tyrosine kinase inhibitors- current status
por: Mughal, Anum, et al.
Publicado: (2013)

Tyrosine kinase c-Abl regulates the survival of plasma cells
por: Li, Yan-Feng, et al.
Publicado: (2017)

Bcr-Abl Tyrosine Kinase Inhibitors in the Treatment of Pediatric CML
por: Carofiglio, Francesca, et al.
Publicado: (2020)

The Role of c-Abl Tyrosine Kinase in Brain and Its Pathologies
por: Motaln, Helena, et al.
Publicado: (2023)

Successful treatment with ABL tyrosine kinase inhibitor for patients with acute myeloid leukemia with BCR-ABL1
por: Takeuchi, Asako, et al.
Publicado: (2020)

A Src-Like Inactive Conformation in the Abl Tyrosine Kinase Domain
por: Levinson, Nicholas M, et al.
Publicado: (2006)

Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade
por: Luttman, Jillian Hattaway, et al.
Publicado: (2021)

Association of Bcr-Abl Tyrosine Kinase Inhibitors With Hepatitis B Virus Reactivation Requiring Antiviral Treatment in Taiwan
por: Wang, Ling-Yi, et al.
Publicado: (2021)

Saponin Inhibits Hepatitis C Virus Propagation by Up-regulating Suppressor of Cytokine Signaling 2
por: Lee, Jihye, et al.
Publicado: (2012)

Rad51 Interacts with Non-structural 3 Protein of Hepatitis C Virus and Regulates Viral Production
por: Son, Kidong, et al.
Publicado: (2017)

Src- and Abl-family kinases activate spleen tyrosine kinase to maximize phagocytosis and Leishmania infection
por: Ullah, Imran, et al.
Publicado: (2023)

Effect of BCR::ABL1 transcript type and droplet digital polymerase chain reaction on successful treatment-free remission in chronic myeloid leukemia patients who discontinued tyrosine kinase inhibitor
por: Park, Hyunkyung, et al.
Publicado: (2023)

Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling
por: Bieerkehazhi, Shayahati, et al.
Publicado: (2016)

Cockayne syndrome protein B interacts with and is phosphorylated by c-Abl tyrosine kinase
por: Imam, Syed Z., et al.
Publicado: (2007)

Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders
por: Mesa, Ruben A
Publicado: (2007)

Cbl-associated protein is tyrosine phosphorylated by c-Abl and c-Src kinases
por: Fernow, Inga, et al.
Publicado: (2009)

BCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia
por: Cuellar, Sandra, et al.
Publicado: (2017)

c-Abl Tyrosine Kinase Adopts Multiple Active Conformational States in Solution
por: Badger, John, et al.
Publicado: (2016)

RUNX2 Phosphorylation by Tyrosine Kinase ABL Promotes Breast Cancer Invasion
por: He, Fang, et al.
Publicado: (2021)

c-Abl Tyrosine Kinase Is Required for BDNF-Induced Dendritic Branching and Growth
por: Chandía-Cristi, América, et al.
Publicado: (2023)

RNA Interference Screen Identifies Abl Kinase and PDGFR Signaling in Chlamydia trachomatis Entry
por: Elwell, Cherilyn A., et al.
Publicado: (2008)

The Role of Receptor Tyrosine Kinases in Lassa Virus Cell Entry
por: Fedeli, Chiara, et al.
Publicado: (2020)

Cross-Talk between Wnt Signaling and Src Tyrosine Kinase
por: Min, Jung Ki, et al.
Publicado: (2022)

Involvement of Rho-Associated Coiled-Coil Containing Kinase (ROCK) in BCR-ABL1 Tyrosine Kinase Inhibitor Cardiovascular Toxicity
por: Yu, Brian, et al.
Publicado: (2022)

CagA Phosphorylation in Helicobacter pylori-Infected B Cells Is Mediated by the Nonreceptor Tyrosine Kinases of the Src and Abl Families
por: Krisch, Linda M., et al.
Publicado: (2016)

Structural and Spectroscopic Analysis of the Kinase Inhibitor Bosutinib and an Isomer of Bosutinib Binding to the Abl Tyrosine Kinase Domain
por: Levinson, Nicholas M., et al.
Publicado: (2012)

Abl Tyrosine Kinase Phosphorylates Nonmuscle Myosin Light Chain Kinase to Regulate Endothelial Barrier Function
por: Dudek, Steven M., et al.
Publicado: (2010)

Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes
por: Fukano, Kento, et al.
Publicado: (2019)

Phosphorylation of Tip60 Tyrosine 327 by Abl Kinase Inhibits HAT Activity through Association with FE65
por: Shin, Sung Hwa, et al.
Publicado: (2013)

Effect of c-Abl tyrosine kinase on the cellular response to paclitaxel-induced microtubule damage
por: Nehmé, A, et al.
Publicado: (2000)

cGMP-mediated antioxidant signaling: a role for the c-Abl tyrosine kinase
por: Stephens, Robert S, et al.
Publicado: (2011)

Importance of adherence to BCR-ABL tyrosine-kinase inhibitors in the treatment of chronic myeloid leukemia
por: de Almeida, Maria Helena, et al.
Publicado: (2014)

Bosutinib: a SRC–ABL tyrosine kinase inhibitor for treatment of chronic myeloid leukemia
por: Rassi, Fuad El, et al.
Publicado: (2013)

Structural and functional dissection of the DH and PH domains of oncogenic Bcr-Abl tyrosine kinase
por: Reckel, Sina, et al.
Publicado: (2017)

A Role for the Non-Receptor Tyrosine Kinase Abl2/Arg in Experimental Neuroinflammation
por: Jacobsen, Freja Aksel, et al.
Publicado: (2018)

Interaction of Abl Tyrosine Kinases with SOCS3 Impairs Its Suppressor Function in Tumorigenesis()()()
por: Feng, Riyue, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hqcjh2lafps5d4ffo78adhqa4s